Literature DB >> 11124696

Management of a Jehovah's witness with thrombotic thrombocytopaenic purpura/haemolytic uraemic syndrome.

M W Drummond, R Green, T Callaghan, D Watson, K Simpson.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11124696     DOI： 10.1002/1098-1101(2000)15:4<266::aid-jca9>3.0.co;2-9

Source DB:  PubMed          Journal:  J Clin Apher        ISSN： 0733-2459            Impact factor:   2.821


× No keyword cloud information.
  2 in total

1.  Early eculizumab use in atypical haemolytic uraemic syndrome in a Jehovah's Witness refusing blood products.

Authors:  May Al-Shaghana; Andrew Bentall; Mark D Jesky; William Lester; Graham Lipkin
Journal:  Oxf Med Case Reports       Date:  2017-06-15

2.  Successful Management of Thrombotic Thrombocytopenic Purpura in a Jehovah's Witness: An Individualized Approach With Joint Decision-Making.

Authors:  Ming Y Lim; Charles S Greenberg
Journal:  J Patient Exp       Date:  2019-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.